Pan P - Search Results

1

In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates.

Ji Y, Chen S, Zhao L, Pan P, Wang L, Cai J, Dai D, Hu G, Cai JP, Huang H. Ji Y, et al. Among authors: pan p. J Clin Pharm Ther. 2015 Jun;40(3):320-7. doi: 10.1111/jcpt.12267. Epub 2015 Apr 17. J Clin Pharm Ther. 2015. PMID: 25884291

2

Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro.

Wang YH, Pan PP, Dai DP, Wang SH, Geng PW, Cai JP, Hu GX. Wang YH, et al. Xenobiotica. 2014 Mar;44(3):270-5. doi: 10.3109/00498254.2013.820007. Epub 2013 Jul 11. Xenobiotica. 2014. PMID: 23844998

3

Determination of metoprolol and its two metabolites in human plasma and urine by high performance liquid chromatography with fluorescence detection and its application in pharmacokinetics.

Xu T, Bao S, Geng P, Luo J, Yu L, Pan P, Chen Y, Hu G. Xu T, et al. Among authors: pan p. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:60-6. doi: 10.1016/j.jchromb.2013.08.017. Epub 2013 Aug 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 24018320

4

Drug-drug interaction of losartan and glimepiride metabolism by recombinant microsome CYP2C9*1, 2C9*3, 2C9*13, and 2C9*16 in vitro.

Chen SZ, Pan PP, Shen LB, Xu SS, Dai DP, Geng PW, Cai J, Cai JP, Hu GX. Chen SZ, et al. Int J Clin Pharmacol Ther. 2014 Sep;52(9):732-8. doi: 10.5414/CP202071. Int J Clin Pharmacol Ther. 2014. PMID: 24986093

5

Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.

Chen M, Zhang Y, Pan P, Wang L, Zhan Y, Jin H, Xia M, Wang X, Dai D, Cai J, Hu G. Chen M, et al. Among authors: pan p. Drug Metab Dispos. 2014 Nov;42(11):1820-5. doi: 10.1124/dmd.114.060244. Epub 2014 Aug 20. Drug Metab Dispos. 2014. PMID: 25142737

6

Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.

Wang L, Bao SH, Pan PP, Xia MM, Chen MC, Liang BQ, Dai DP, Cai JP, Hu GX. Wang L, et al. Drug Dev Ind Pharm. 2015;41(8):1363-7. doi: 10.3109/03639045.2014.950274. Epub 2014 Aug 21. Drug Dev Ind Pharm. 2015. PMID: 25144335

7

The role of CYP2C9 genetic polymorphism in carvedilol O-desmethylation in vitro.

Pan PP, Weng QH, Zhou CJ, Wei YL, Wang L, Dai DP, Cai JP, Hu GX. Pan PP, et al. Eur J Drug Metab Pharmacokinet. 2016 Feb;41(1):79-86. doi: 10.1007/s13318-014-0245-2. Epub 2014 Dec 5. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25476996

8

In vitro and in vivo characterization of 13 CYP2C9 allelic variants found in Chinese Han population.

Hu GX, Pan PP, Wang ZS, Yang LP, Dai DP, Wang SH, Zhu GH, Qiu XJ, Xu T, Luo J, Lian QQ, Ge RS, Cai JP. Hu GX, et al. Drug Metab Dispos. 2015 Apr;43(4):561-9. doi: 10.1124/dmd.114.061200. Epub 2015 Jan 22. Drug Metab Dispos. 2015. PMID: 25614704

9

In vitro and in vivo drug-drug interaction of losartan and glimepiride in rats and its possible mechanism.

Chen SZ, Pan PP, Wang SH, Luo J, Hu GX, Xu SS, Zhang L, Yu YF. Chen SZ, et al. Pharmacology. 2015;95(3-4):133-8. doi: 10.1159/000377637. Epub 2015 Mar 25. Pharmacology. 2015. PMID: 25823852

10

Impact of CYP2C9 polymorphism found in the Chinese population on the metabolism of propofol in vitro.

Lian QQ, Pan PP, Li JW, Lin H, Hu GX, Zuo MZ, Cai JP. Lian QQ, et al. Biol Pharm Bull. 2015;38(4):531-5. doi: 10.1248/bpb.b14-00671. Biol Pharm Bull. 2015. PMID: 25832633 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,802 results

Search Page